CompaniesEpigen

Epigen

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

1

As Collaborator

5

Total Enrollment

1,166

By Phase

PHASE3: 2PHASE1: 1NA: 1

By Status

RECRUITING: 3NOT_YET_RECRUITING: 1UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT01354171
NCT06272864
NCT06789172
Hover over trial bars to see details

Recent Trials

NCT06024772Collaborator
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
PHASE3Not yet recruiting
300 participants
Started: Nov 30, 2025 · Completed: Feb 28, 2027
NCT06789172Lead Sponsor
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
PHASE1Recruiting
166 participants
Started: Jan 23, 2025 · Completed: Sep 30, 2028
NCT06272864Collaborator
BostonGene and Exigent Genomic INsight Study
N/ARecruiting
400 participants
Started: Apr 8, 2024 · Completed: Jan 8, 2028
NCT05977621Collaborator
Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
N/ARecruiting
7 participants
Started: Feb 7, 2024 · Completed: Feb 28, 2026
NCT01354171Collaborator
Active Surveillance Magnetic Resonance Imaging Study
PHASE3Unknown
250 participants
Started: Nov 30, 2011 · Completed: Dec 31, 2017
View all 6 trials →
Funding History (5)
DEF 14C
Nov 18, 2002
Filing
DEF 14C
Oct 18, 2001
Filing
8-K
Aug 8, 2000
Filing
8-K
Jun 15, 1999
Filing
8-K
Mar 25, 1999
Filing